AMZN
Amazon.com, Inc.
AMZN has the edge over CAVA overall, supported by stronger valuation and lower modeled downside.
CAVA
CAVA Group, Inc.
CAVA's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
CAVA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Strong |
CAVA's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over CAVA in the historical PE scenario, which offers more potential upside but is not a forecast.
CAVA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 53x | $28.53 | -50% |
| Fair | 75x | $40.72 | -29% |
| Forward | 84x | $57.35 | — |
| Current | 106x | $57.35 | — |
| Expensive | 147x | $79.57 | +39% |
Historical ranges are pointers, not guarantees.
CAVA's PE is in its fair range at 106x. If earnings grow as analysts expect, today's price would be 84x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
CAVA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Moderate | |
| Low |
CAVA has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over CAVA on earnings, with more consistent year-over-year improvement.
CAVA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.69 | +27% |
| Q3 2026 | $0.54 | -53% |
| Q2 2026 | $0.55 | -54% |
| Q2 2026 | $0.52 | -57% |
| Q4 2025 | $0.54 | -51% |
CAVA's earnings per share have fallen from their peak: $0.54 over the past year, against $1.20 in early 2025.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over CAVA on profitability, with a higher operating margin.
CAVA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $356.4M | +22% |
| Q2 2026 | $368.4M | +31% |
| Q2 2026 | $438.3M | +32% |
| Q4 2025 | $275M | +21% |
| Q3 2025 | $292.2M | +20% |
| Q2 2025 | $280.6M | +20% |
| Q2 2025 | $331.8M | +28% |
| Q4 2024 | $227.4M | +28% |
CAVA has the edge over AMZN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.2% | -1.7 points |
| Q2 2026 | 7.3% | +0.3 points |
| Q2 2026 | 5.8% | +1 points |
| Q4 2025 | 1% | -0.7 points |
| Q3 2025 | 5.9% | +0.2 points |
| Q2 2025 | 7% | +0.1 points |
| Q2 2025 | 4.7% | +1.2 points |
| Q4 2024 | 1.7% | +2.6 points |
CAVA's operating margin was 4.2% last quarter, down 1.7 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
CAVA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$7.7M | -661% |
| Q2 2026 | $29.3M | +53% |
| Q2 2026 | $15.5M | +473% |
| Q4 2025 | $2.9M | +36% |
| Q3 2025 | $1.4M | -94% |
| Q2 2025 | $19.2M | -15% |
| Q2 2025 | $2.7M | -42% |
| Q4 2024 | $2.1M | +$9.3M |
CAVA has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
CAVA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -93K shares |
| 1 year | 0% | +15K shares |
| 3 years | +278% | +87M shares |
CAVA has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2023 | $1.5M |
| Q3 2023 | $105,000 |
| Q2 2023 | $1.4M |
| Q4 2022 | $250,000 |
| Q3 2022 | $19,000 |
| Q2 2022 | $13,000 |
| Q2 2022 | $629,000 |
| Q4 2021 | $156,000 |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CAVA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.9x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q4 2025 | -2.2x | Net Cash |
| Q3 2025 | -2.3x | Net Cash |
| Q2 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.6x | Net Cash |
| Q4 2024 | -3.5x | Net Cash |
CAVA has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
CAVA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.6 | Neutral |
| Stochastic | 33.6 | Neutral |
CAVA's weekly RSI is 44 (neutral) and its Stochastic is 34 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over CAVA on valuation relative to its sector.
CAVA PE vs Consumer Cyclical Sector
| Metric | CAVA | Sector median | Relative |
|---|---|---|---|
| PE | 106x | 18x | 489% above |
| PE % | 62 | 36 | 26 pts above |
CAVA is trading at 106x earnings, a 489% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has stronger trend alignment. AMZN is above 5 of 5 weekly averages versus CAVA above 1 of 4.
CAVA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $55.7 | 3% above |
| 20 week MA | $61.8 | 7.2% below |
| 50 week MA | $69.9 | 18% below |
| 100 week MA | $77.2 | 26% below |
CAVA has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 26% below its 100-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over CAVA on returns for 2026, with the stronger performance.
CAVA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $38.2 | $43.0 | +13% |
| 2024 | $43.0 | $114.4 | +166% |
| 2025 | $114.4 | $60.2 | -47% |
| 2026 YTD | $60.2 | $57.4 | -4.7% |
CAVA's yearly returns have swung widely, from +166% in 2024 to −47% in 2025. It's down 4.7% so far in 2026.